Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
25 S&P 500 Stocks to Target Next Month
08:00am, Friday, 28'th Jul 2023
Subscribers to Chart of the Week received this commentary on Sunday, July 23.
Dexcom, Inc. (DXCM) Q2 2023 Earnings Call Transcript
08:14pm, Thursday, 27'th Jul 2023
Dexcom, Inc. (NASDAQ:DXCM ) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairman,
DexCom (DXCM) Beats Q2 Earnings and Revenue Estimates
07:14pm, Thursday, 27'th Jul 2023
DexCom (DXCM) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.17 per share a year ago.
Dexcom lifts revenue forecast on demand for glucose-monitoring devices
05:02pm, Thursday, 27'th Jul 2023
Medical device maker Dexcom Inc on Thursday raised its annual revenue forecast after strong demand for its continuous glucose monitoring (CGM) systems boosted second-quarter results, lifting its share
EVP Managing Director Steven Pacelli Sells 412 Shares of DexCom Inc
12:01pm, Tuesday, 25'th Jul 2023
On July 24, 2023, Steven Pacelli, the Executive Vice President and Managing Director of DexCom Inc ( DXCM , Financial), sold 412 shares of the company. This move is part of a broader trend of insider
Healthcare creating more opportunities for tech investors, says Harris Financial's Jamie Cox
02:48pm, Friday, 21'st Jul 2023
Jamie Cox, Harris Financial Group managing partner, joins 'The Exchange' to discuss investment opportunities in medical devices, the intersection of healthcare and technology, and top picks in the med
These 13 S&P 500 stocks stand out for expected growth through 2025
10:42am, Thursday, 20'th Jul 2023
As the 2023 stock-market rally continues, this is a good time to look further ahead to see which companies are expected to show the highest growth rates through 2025.
Here is Why Growth Investors Should Buy DexCom (DXCM) Now
02:09pm, Friday, 14'th Jul 2023
DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.
DexCom (DXCM) Stock Hits 52-Week High: More Room to Grow?
09:39am, Friday, 14'th Jul 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
2 Growth Stocks That Could Double in 5 Years
10:15am, Friday, 07'th Jul 2023
DexCom is making continuous glucose monitoring technology more widespread. Etsy is highly successful in its small corner of the large e-commerce industry.
DexCom's (DXCM) G7 CGM System Gets Nod From Health Canada
11:32am, Wednesday, 05'th Jul 2023
DexCom's (DXCM) G7 CGM System's latest approval by Health Canada is expected to combine simplicity and power, thereby providing a better way to manage diabetes.
Looking for a Growth Stock? 3 Reasons Why DexCom (DXCM) is a Solid Choice
02:21pm, Wednesday, 28'th Jun 2023
DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.
Dexcom (DXCM) to Launch New Product in 2024, Ups Long-Term View
09:48am, Tuesday, 27'th Jun 2023
Dexcom (DXCM) announces encouraging developments in 2024, including faster coverage for its products by private payers and new product launch for diabetic patients not on insulin.
Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market
08:15pm, Friday, 23'rd Jun 2023
Dexcom's revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device. Dexcom stock could soar again.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio
06:35am, Thursday, 22'nd Jun 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
